Tumor volume in mice xenografted with osteosarcoma cells expressing ATG4D‐targeting shRNA exhibited a significant weekly decrease compared to tumors derived from nontarget osteosarcoma cells (Figure 5A,B). Here, ATG4D is linked to neoplasm.